Form 4: VolitionRx Officer's Tax Withholding Transaction

VolitionRx GC Nicholas Plummer's Form 4 filing details the withholding of 5,647 common shares for tax obligations related to RSU settlement.

Summary

• Nicholas Plummer, General Counsel (GC) of Volition Diagnostics, a subsidiary of VolitionRx Ltd (VNRX), filed a Form 4.
• The filing reports a transaction on November 1, 2025, involving the disposition of 5,647 shares of VolitionRx Common Stock.
• These shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations.
• The tax obligations arose from the settlement of 12,016 restricted stock units (RSUs) awarded to Mr. Plummer in lieu of cash compensation.
• The price per share for the disposition was $0.434.
• Following this transaction, Nicholas Plummer beneficially owns 194,084 shares of Common Stock directly.
• No shares were sold by Mr. Plummer or VolitionRx in this transaction; it was solely for tax purposes.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While shares were 'disposed of,' it was a non-discretionary tax withholding event following the vesting of RSUs, which is a positive for the insider's compensation. It does not indicate any negative sentiment towards the company by the insider.

Positives

• The transaction represents the vesting and settlement of restricted stock units, indicating compensation for the reporting person.
• The disposition of shares was solely for tax withholding purposes, not a discretionary sale by the officer, which is a routine and expected event.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not reflect a change in the insider's investment thesis or a significant shift in ownership structure.
• Employees: No direct impact beyond the reporting person, as it relates to individual compensation.

Key Dates

Recommendation

This Form 4 filing details a routine tax withholding transaction related to the vesting of restricted stock units for an officer. It is a non-discretionary event and does not provide new information that would alter the fundamental investment thesis for VolitionRx Ltd. Therefore, a 'hold' recommendation is appropriate, as this filing alone does not present a compelling reason to buy or sell the stock.

Keywords

VNRX, VolitionRx, Form 4, insider transaction, restricted stock units, RSU, tax withholding, Nicholas Plummer, corporate governance